The enhanced bactericidal activity of macrophages against intracellular parasites is involved in the mechanism of cell-mediated immunity (11, 12, 20) . In infections, cell-mediated immunity is based on the generation of sensitized lymphocytes which release lymphokines when they react with a specific antigen. Macrophage activating factor (MAF), one of the lymphokines, enhances the microbicidal (1, (7) (8) (9) 20) and tumoricidal (17, 19) activity of macrophages. On the other hand, Mackaness (12) suggested that cellular immunity is causally related to a systemic delayed-type hypersensitivity (DTH) reaction against the primary infecting organism. Dodd (5) reported that in guinea pigs free of primary infection, resistance to Listeria monocytogenes was induced by a systemic DTH reaction to bovine gamma globulin. These observations suggest that lymphokine(s) induced in different ways may be solely responsible for cell-mediated immunity to intracellular parasites. In this study, we examined the resistance of mice to Salmonella infection in a modified state completely unrelated to primary infection or specific vaccination. We used mice which exhibited a DTH reaction after bovine serum albumin (BSA) immunization and normal mice that had been injected with a lymphokine-rich fraction of a concanavalin A (ConA)-stimulated supernatant. Although the DTH reaction comprises complicated events other than macrophage activation (14) , in this study of the systemic DTH reaction we take into account only the possible effects of resident macrophages on acquired resistance to infection. Seven-week-old C57BL/6 mice were subcutaneously immunized with 1 mg of BSA (Miles Laboratories, Inc., Elkhart, Ind.) in 0.2 ml of Freund complete adjuvant (FCA) emulsion. Three weeks later, when they exhibited positive footpad reaction, they were injected i.p. with BSA in saline. They were then infected 2 h later with S. typhimurium. The BSA solution was not contaminated with lipopolysaccharide (<0.25 ng/mg) when assayed by gelation of Limulus amoebocyte lysate with Pyrotest (Difco). To determine the optimal BSA stimulation dose, immunized mice were injected i.p. with 10, 100, or 1,000 p.g of BSA in saline and infected with S. typhimurium. For 5 days postinfection, challenge with 10 jig of BSA markedly suppressed bacterial growth in the liver and spleen (Fig. 1) . In recipients of the higher stimulation doses, bacterial multiplication was similar to that of control mice which had been BSA immunized but not subsequently challenged. Thus, we used 10 ,ug of BSA for the stimulation of immunized mice. typhimurium. The total number of bacteria in the spleen and liver was determined.
The effect of BSA immunization and challenge on total bacterial growth in the spleen and liver was assessed at predetermined postinfection intervals (Fig. 2) . In immunized, nonstimulated mice, bacterial growth in the spleen and liver was similar to that in the controls, and mice treated with FCA alone and injected with BSA also showed bacterial growth similar to that of the controls. In contrast, in immunized mice that had been challenged with BSA, a decrease in the number of bacteria occurred between days 5 and 10 postinfection. The difference in the number of bacteria in control and immunized, BSA-stimulated mice was up to 100-fold (P < 0.01). Although it appears that the number of living bacteria in vivo induced from the experiment with just three mice per each group might be unbelievable, the preliminary experiments with three mice per each group showed results similar to the experiments shown in Fig. 1 and 2 . However, additional experiments with adequate numbers of mice should be performed. These results indicate that in immunized, challenged mice, the systemic DTH reaction to BSA enhanced the resistance to S. typhimurium infection, suggesting that the specifically released MAF may activate macrophages.
The lymphokine-rich fraction of a Con Astimulated supernatant was obtained as described previously and concentrated to 4% of the original supernatant volume (8) . Sevenweek-old BDF1 mice were injected i.p. with 0.4 ml of the lymphokine-rich fraction, with a control fraction which was prepared from a supematant of spleen cell culture without Con A stimulation, or with phosphate-buffered saline. Two days later, they were infected i.p. with four times the LD50 of S. typhimurium, and the number of bacteria in the livers and spleens was determined at 2-to 4-day intervals. In the livers and spleens of mice that had received one injection of the lymphokine-rich fraction at 2 days before infection, we noted a significantly lower (P < 0.05) number of bacteria at days 3 and 5 postinfection than in phosphate-buffered salinetreated controls. However, at 7 days postinfection, the number of bacteria in control and lymphokine-treated mice was similar (Fig. 3A) . Mice treated with the control fraction 2 days before infection showed the same number of bacteria as controls at days 3 and 5 postinfection (data not shown). When mice were treated with the lymphokine-rich fraction 2 days before and again 2 days after infection, the effect of MAF on bacterial growth was somewhat enhanced; on day 7 postinfection, lymphokine-treated mice showed a decrease in the number of bacteria (Fig. 3B) . When mice were treated with lymphokine three times, i.e., 2 days before and 2 and 6 days after infection, the number of bacteria in the spleen and liver was significantly suppressed for 14 days (Fig. 3C) . These results indicate that vivo and enhances their intracellular killing of S. typhimurium in a dose-dependent manner. These findings coincide with our previously reported in vitro observations (8) .
In mice, the defense against salmonellosis is related to the development of a T-lymphocytemediated immune response (3, 21, 23) . In this study, we demonstrated the resistance to S. typhimurium infection of mice without primary infection or vaccination with Salmonella sp. We induced a systemic DTH reaction by immunizing one group with BSA and subsequently challenged them; the other group received an i.p. injection of the lymphokine-rich fraction of a Con A-stimulated supernatant.
In the first group, we found it difficult to ascertain the optimal dose of the stimulating antigen for obtaining a DTH reaction (Fig. 1) (2) . On the other hand, our lymphokine treatment experiment suggests that the effect of MAF on murine resistance to S. typhimurium infection is dose dependent.
Several studies which used lymphokine(s) in the treatment of murine tumors have been reported (6, 13, 15) . However, little attention has been paid to the in vivo applicability of lymphokine(s) in the control of infection with intracellular parasites.
In the host defense system, there is a state in which cell-mediated immunity is deficient owing to a T-cell defect; this is occasionally followed by chronic mucocutaneous candidiasis (10, 16) or cryptococcosis (4, 18) . However, macrophage function is usually normal in these states. Therefore, the experiments presented here suggest the possibility that self-induced or transferred lymphokine(s), if available in sufficient quantity, may help to control infection with intracellular parasites, especially in immunodeficient patients. The optimal dose and timing for the administration of lymphokine(s) require further study.
